DCT and melanoma: The use of peptides derived from TRP2 that is differentially expressed in melanoma cells and melanocytes provides a rodent model that closely mimics human melanoma without introduction of xenogenic or otherwise foreign antigen (19), clearly demonstrating the ability of this particles to break self-tolerance.